Atrial natriuretic peptide reduces hepatic ischemia-reperfusion injury in rabbits

Journal of Anesthesia

Volumn 27, Issue 6, 2013, Pages 901-908

  Yamada, Takashige ^a   Kotake, Yoshifumi ^b   Nagata, Hiromasa ^a   Takeda, Junzo ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Atrial natriuretic peptide; Ischemia reperfusion; Liver injury; Tissue microvascular blood flow

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ATRIAL NATRIURETIC FACTOR; GALACTOSE; PENTOBARBITAL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA FLOW; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD GAS; COLOR ULTRASOUND FLOWMETRY; CONTINUOUS INFUSION; CONTROLLED STUDY; EXPERIMENTAL RABBIT; HEART RATE; HEMODYNAMICS; HEPATIC ARTERY; HISTOPATHOLOGY; HYDROGEN CLEARANCE; LIVER BLOOD FLOW; LIVER CELL; LIVER INJURY; LIVER ISCHEMIA; LIVER PROTECTION; MALE; MEAN ARTERIAL PRESSURE; METABOLIC CLEARANCE RATE; MICROVASCULARIZATION; NONHUMAN; PORTAL VEIN; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; ARTERIAL PRESSURE; ATRIAL NATRIURETIC FACTOR; GALACTOSE; HEART RATE; HEMODYNAMICS; LIVER; LIVER CIRCULATION; LIVER FUNCTION TESTS; MALE; MICROCIRCULATION; RABBITS; RANDOM ALLOCATION; REPERFUSION INJURY;

EID: 84891484089     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-013-1643-3     Document Type: Article

References (30)

1. Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev. 2009;89:1269-339.
2. Klune JR, Tsung A. Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements. Surg Clin N Am. 2010;90:665-77.
3. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, Jochum W. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg. 2003;238:843-50.
4. Beck-Schimmer B, Breitenstein S, Urech S, De Conno E, Wittlinger M, Puhan M, Jochum W, Spahn DR, Graf R, Clavien PA. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg. 2008;248:909-18.
5. Cottart CH, Nivet-Antoine V, Do L, Al-Massarani G, Descamps G, Xavier-Galen F, Clot JP. Hepatic cytoprotection by nitric oxide and the cGMP pathway after ischaemia-reperfusion in the rat. Nitric Oxide. 2003;9:57-63.
6. Gerwig T, Meissner H, Bilzer M, Kiemer AK, Arnholdt H, Vollmar AM, Gerbes AL. Atrial natriuretic peptide preconditioning protects against hepatic preservation injury by attenuating necrotic and apoptotic cell death. J Hepatol. 2003;39:341-8.
7. Kobayashi K, Oshima K, Muraoka M, Akao T, Totsuka O, Shimizu H, Sato H, Tanaka K, Konno K, Matsumoto K, Takeyoshi I. Effect of atrial natriuretic peptide on ischemia-reperfusion injury in a porcine total hepatic vascular exclusion model. World J Gastroenterol. 2007;13:3487-92.
8. Young W. H2 clearance measurement of blood flow: a review of technique and polarographic principles. Stroke. 1980;11:552-64.
9. Hoekstra LT, de Graaf W, Nibourg GA, Heger M, Bennink RJ, Stieger B, van Gulik TM. Physiological and biochemical basis of clinical liver function tests: a review. Ann Surg. 2013;257:27-36.
10. Li W, Meng Z, Liu Y, Patel RP, Lang JD. The hepatoprotective effect of sodium nitrite on cold ischemia-reperfusion injury. J Transplant. 2012. doi: 10.1155/2012/635179.
11. Kallaras K, Babas G, Stergiou-Michailidou V, Karamouzis M, Zaraboukas T. Atrial natriuretic peptide decreases aorta stiffness in cholesterol-fed anesthetized rabbits. Pharmacol Res. 2009;60:324-31.
12. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998;339:321-8.
13. Merkel C, Marchesini G, Fabbri A, Bianco S, Bianchi G, Enzo E, Sacerdoti D, Zoli M, Gatta A. The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. Hepatology. 1996;24:820-3.
14. Garello E, Battista S, Bar F, Niro GA, Cappello N, Rizzetto M, Molino G. Evaluation of hepatic function in liver cirrhosis: clinical utility of galactose elimination capacity, hepatic clearance of D-sorbitol, and laboratory investigations. Dig Dis Sci. 1999;44:782-8.
15. Redaelli CA, Dufour JF, Wagner M, Schilling M, Husler J, Krahenbuhl L, Buchler MW, Reichen J. Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg. 2002;235:77-85.
16. Lentsch AB, Kato A, Yoshidome H, McMasters KM, Edwards MJ. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology. 2000;32:169-73.
17. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284:G15-26.
18. Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006;290:G1083-8.
19. Kiemer AK, Baron A, Gerbes AL, Bilzer M, Vollmar AM. The atrial natriuretic peptide as a regulator of Kupffer cell functions. Shock. 2002;17:365-71.
20. Arii S, Imamura M. Physiological role of sinusoidal endothelial cells and Kupffer cells and their implication in the pathogenesis of liver injury. J Hepatobiliary Pancreat Surg. 2000;7:40-8.
21. Teoh NC, Farrell GC. Hepatic ischemia reperfusion injury: pathogenic mechanisms and basis for hepatoprotection. J Gastroenterol Hepatol. 2003;18:891-902.
22. Gujral JS, Bucci TJ, Farhood A, Jaeschke H. Mechanism of cell death during warm hepatic ischemia-reperfusion in rats: apoptosis or necrosis? Hepatology. 2001;33:397-405.
23. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation. 1999;67:1099-105.
24. Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T, Nagai Y, Nanto S, Watanabe K, Fukuzawa S, Hirayama A, Nakamura N, Kimura K, Fujii K, Ishihara M, Saito Y, Tomoike H, Kitamura S. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet. 2007;370:1483-93.
25. Mitaka C, Kudo T, Jibiki M, Sugano N, Inoue Y, Makita K, Imai T. Effects of human atrial natriuretic peptide on renal function in patients undergoing abdominal aortic aneurysm repair. Crit Care Med. 2008;36:745-51.
26. Bilzer M, Jaeschke H, Vollmar AM, Paumgartner G, Gerbes AL. Prevention of Kupffer cell-induced oxidant injury in rat liver by atrial natriuretic peptide. Am J Physiol. 1999;276:G1137-44.
27. Kiemer AK, Vollmar AM, Bilzer M, Gerwig T, Gerbes AL. Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J Hepatol. 2000;33:236-46.
28. Kiemer AK, Hartung T, Vollmar AM. cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J Immunol. 2000;165:175-81.
29. Kiemer AK, Gerbes AL, Bilzer M, Vollmar AM. The atrial natriuretic peptide and cGMP: novel activators of the heat shock response in rat livers. Hepatology. 2002;35:88-94.
30. Ishigaki N, Yamamoto N, Jin H, Uchida K, Terai S, Sakaida I. Continuous intravenous infusion of atrial natriuretic peptide (ANP) prevented liver fibrosis in rat. Biochem Biophys Res Commun. 2009;378:354-9.